Aprepitant, a Novel Neurokinin-1 Receptor Antagonist in Management of Chemotherapy Induces Nausea Vomiting (CINV) in Cancer Patients. Int. J. Res. Clin. Hosp. Pharm. 2019, 2 (1), 1-4.